Prominence of IL6, IGF, TLR, and Bioenergetics Pathway Perturbation in Lung Tissues of Scleroderma Patients With Pulmonary Fibrosis
Scleroderma-associated pulmonary fibrosis (SSc-PF) and idiopathic pulmonary fibrosis (IPF) are two of many chronic fibroproliferative diseases that are responsible for nearly 45% of all deaths in developed countries. While sharing several pathobiological characteristics, they also have very distinct...
Main Authors: | Ludivine Renaud, Willian A. da Silveira, Naoko Takamura, Gary Hardiman, Carol Feghali-Bostwick |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-03-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2020.00383/full |
Similar Items
-
Scleroderma with Nodular Scleroderma
by: Chutika Srisuttiyakorn, et al.
Published: (2016-11-01) -
Diagnosis and treatment of interstitial lung disease in scleroderma systematica
by: L. P. Ananyeva
Published: (2018-06-01) -
UNILATERAL LUNG INJURY IN SCLERODERMA SYSTEMATICA: A CASE REPORT
by: R. T. Alekperov, et al.
Published: (2014-09-01) -
IMPORTANCE OF CYCLOPHOSPHANUM IN THE TREATMENT OF INTERSTITIAL LUNG LESION IN PATIENTS WITH SCLERODERMA SYSTEMATICA (A REVIEW OF LITERATURE)
by: Olga Aleksandrova Koneva
Published: (2010-06-01) -
A case of sine scleroderma with parenchymal lung disease
by: Mansoor Karimifar, et al.
Published: (2014-01-01)